Industry › Healthcare & Pharm

Press Releases

Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX

Nov 07, 2022 15:49 HKT/SGT

ニュートンバイオキャピタル、和田道彦博士とフィリップデバッカー博士の参画で、チーム体制をさらに強化

Nov 07, 2022 13:00 JST

ニュートンバイオキャピタル、和田道彦博士とフィリップデバッカー博士の参画で、チーム体制をさらに強化

Nov 07, 2022 13:00 JST

Eisai to Divest Rights for Muscle Relaxant Myonal, Vertigo, and Equilibrium Disturbance Treatment Merislon in Asia to DKSH

Nov 07, 2022 08:15 HKT/SGT

Handover of National Centre for Pandemic and Infection Diseases in Myanmar; Advanced Facility Built with Donation from AW Foundation

Nov 05, 2022 12:45 HKT/SGT

中国抗体宣布委任王善春先生为中国区总裁

Nov 04, 2022 17:49 HKT/SGT

中國抗體宣佈委任王善春先生為中國區總裁

Nov 04, 2022 17:48 HKT/SGT

SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company

Nov 04, 2022 17:47 HKT/SGT

Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of Drug Reexamination

Nov 02, 2022 09:43 HKT/SGT

Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round

Nov 01, 2022 18:05 HKT/SGT

Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round

Nov 01, 2022 17:51 HKT/SGT

Inaugural International Healthcare Week promotes Hong Kong as leading healthcare hub

Oct 31, 2022 19:00 HKT/SGT

兆科眼科的合作伙伴Vyluma发表用于治疗儿童近视加深的NVK002之第III期CHAMP临床试验的正面研究结果

Oct 28, 2022 09:47 HKT/SGT

兆科眼科的合作夥伴Vyluma發表用於治療兒童近視加深的NVK002之第III期CHAMP臨床試驗的正面研究結果

Oct 28, 2022 09:46 HKT/SGT

Zhaoke Ophthalmology's Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children

Oct 28, 2022 09:45 HKT/SGT

Avance Clinical贊助全球Scrip獎項的中國生物製藥獎

Oct 27, 2022 08:00 HKT/SGT

Avance Clinical赞助全球Scrip奖项的中国生物制药奖

Oct 27, 2022 08:00 HKT/SGT

중국에서의 임상 연구 기회와 미국 식품의약국 승인 경로 – 백서

Oct 27, 2022 07:00 HKT/SGT

Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE

Oct 26, 2022 19:00 HKT/SGT

云康集团（02325.HK）荣获香港股票分析师协会《上市公司年度大奖2022》

Oct 26, 2022 18:19 HKT/SGT